Alzheimer's Disease Research (ADR) funds cutting-edge research to stop Alzheimer's disease and provides free information to the public about risk factors, preventive lifestyles, treatments, and coping strategies.
The toll that Alzheimer's disease will place on the health care system, patients, and families makes it imperative that a cure be found. Alzheimer's disease is projected to affect 15 million Americans by 2050 if no adequate treatments or a cure is found. Currently, the cost of caring for Alzheimer's disease patients nationwide, including health care expenses and lost wages of both patients and their caregivers, is estimated at $200 billion per year.
ADR is a leading funder of basic scientific research to discover treatments Alzheimer's disease. We have awarded more than $82.5 million in research grants to leading researchers around the world.
Donors who invest in research affect the lives of millions of people impacted by Alzheimer's. With your generous contributions, ADR provides free educational materials and funds the research of hard-working scientists as together we battle the damaging effects of this devastating neurological condition.
Alzheimer's Disease is a program of BrightFocus Foundation. BrightFocus seeks to save mind and sight by funding innovative research worldwide and by promoting better health through education.
We envision a world where everyone lives with clarity, grace, and good health.
In addition to our investment in Alzheimer's disease, BrightFocus is a leading funder of research into the causes, treatments, and cures for age-related macular degeneration and glaucoma.